M
Michael Bauer Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
High Impact
Assitstant Professor
faculty
25 h-index
396 pubs
3,343 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Michael Bauer's research group at the University of Arkansas for Medical Sciences focuses on the molecular and genomic underpinnings of multiple myeloma. His work has investigated the evolutionary pathways from precursor stages to active disease, including the role of smoldering myeloma and the spatio-temporal evolution of the cancer from baseline to relapse-refractory states. Dr. Bauer has also explored pathogenic drivers such as chromothripsis and structural variants that shape the genomic landscape and influence clinical outcomes.
Further research by Dr. Bauer's group examines the immune microenvironment in multiple myeloma and its precursor stages, utilizing single-cell characterization and multi-omics approaches to understand alterations. His publications also extend to other areas, including the association of low-level environmental heavy metals with obesity among postmenopausal women and genome-wide DNA methylation signatures predicting doxorubicin-induced cardiotoxicity in breast cancer.
Dr. Bauer holds a high-impact researcher designation, evidenced by his h-index of 24 and over 3,272 citations across 396 publications. He collaborates with several researchers at the University of Arkansas for Medical Sciences, including Cody Ashby, Christopher P. Wardell, Sharmilan Thanendrarajan, and Maurizio Zangari, with whom he shares multiple publications.
Metrics
- h-index: 25
- Publications: 396
- Citations: 3,343
Selected Publications
-
Loss of FAM60A disrupts Sin3/HDAC control of the Hippo signaling and promotes oncogenic YAP1 activation (2026)
-
Folinic Acid Improves Healing of Diabetic Foot Ulcers (2026)
-
Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte function (2026)
-
How Does Age at Diagnosis Influence Multiple Myeloma Survival? Empirical Evidence (2025)
-
Start Time End Time Integration (STETI): Method for Including Recent Data to Analyze Trends in Kidney Cancer Survival (2025)
-
Multi-Omics Reveal Immune Microenvironment Alterations in Multiple Myeloma and Its Precursor Stages (2024)
-
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages (2024)
-
RNA sequencing of formalin fixed paraffin-embedded heart tissue provides transcriptomic information about chemotherapy-induced cardiotoxicity (2024)
-
Increased Utilization of Low-Dose CT for Lung Cancer Screening at an Arkansas Community Oncology Clinic (2023)
-
1211 Defining the role of PCK2 in T cell metabolic plasticity in Glioblastoma (2023)
-
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma (2023)
-
EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression (2023)
-
Abstract B015: Racial differences in epigenetic aging and its impact on expression of T-cell inhibitory receptors (2023)
-
Identification of novel long noncoding RNA with distinct expression patterns in different subtypes of multiple myeloma (2022)
-
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level (2022)
Grants & Funding
Collaboration Network
Top Collaborators
Eileen M. Boyle
25 shared publications
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- Chromothripsis as a pathogenic driver of multiple myeloma
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
Showing 5 of 25 shared publications
Brian A. Walker
23 shared publications
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Chromothripsis as a pathogenic driver of multiple myeloma
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Showing 5 of 23 shared publications
Francesco Maura
19 shared publications
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Chromothripsis as a pathogenic driver of multiple myeloma
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Showing 5 of 19 shared publications
Ola Landgren
19 shared publications
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Chromothripsis as a pathogenic driver of multiple myeloma
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Showing 5 of 19 shared publications
Cody Ashby
University of Arkansas for Medical Sciences
18 shared publications
In database
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Chromothripsis as a pathogenic driver of multiple myeloma
- Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Showing 5 of 18 shared publications
Patrick Blaney
18 shared publications
- Chromothripsis as a pathogenic driver of multiple myeloma
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
- Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer
Showing 5 of 18 shared publications
Yubao Wang
18 shared publications
- Chromothripsis as a pathogenic driver of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
- Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
Showing 5 of 18 shared publications
Hussein Ghamlouch
18 shared publications
- Chromothripsis as a pathogenic driver of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
- Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer
- Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups
Showing 5 of 18 shared publications
Louis Williams
18 shared publications
- Chromothripsis as a pathogenic driver of multiple myeloma
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
- Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer
Showing 5 of 18 shared publications
Marc Braunstein
17 shared publications
- Chromothripsis as a pathogenic driver of multiple myeloma
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
- Hispanic or Latin American Ancestry Is Associated with a Similar Genomic Profile and a Trend Toward Inferior Outcomes in Newly Diagnosed Multiple Myeloma As Compared to Non-Hispanic White Patients in the Multiple Myeloma Research Foundation (MMRF) CoMMpassstudy
Showing 5 of 17 shared publications
Arnaldo Arbini
16 shared publications
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
- Hispanic or Latin American Ancestry Is Associated with a Similar Genomic Profile and a Trend Toward Inferior Outcomes in Newly Diagnosed Multiple Myeloma As Compared to Non-Hispanic White Patients in the Multiple Myeloma Research Foundation (MMRF) CoMMpassstudy
- Data from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Showing 5 of 16 shared publications
Faith E. Davies
NYU Langone Health (US)
16 shared publications
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- Chromothripsis as a pathogenic driver of multiple myeloma
- Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Showing 5 of 16 shared publications
Frits van Rhee
University of Arkansas for Medical Sciences
15 shared publications
In database
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages
- High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma
Showing 5 of 15 shared publications
Carolina Schinke
University of Arkansas for Medical Sciences
15 shared publications
In database
- The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
- The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
- Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
- Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages
- High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma
Showing 5 of 15 shared publications
James H. Stoeckle
15 shared publications
- Chromothripsis as a pathogenic driver of multiple myeloma
- Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
- Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
- Hispanic or Latin American Ancestry Is Associated with a Similar Genomic Profile and a Trend Toward Inferior Outcomes in Newly Diagnosed Multiple Myeloma As Compared to Non-Hispanic White Patients in the Multiple Myeloma Research Foundation (MMRF) CoMMpassstudy
- Data from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Showing 5 of 15 shared publications
Similar Researchers
Based on overlapping research topics
Sarah K. Johnson
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Genomics and Diagnostics
Genomics and Phylogenetic Studies
Lora J. Rogers
University of Arkansas for Medical Sciences
Cancer Genomics and Diagnostics
Immune Response and Inflammation
Epigenetics and DNA Methylation
Qingyang Zhang
University of Arkansas at Fayetteville
Genomics and Phylogenetic Studies
Immune Response and Inflammation
Epigenetics and DNA Methylation
Cody Ashby
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Genomics and Phylogenetic Studies
Immune Response and Inflammation
Madeline Brown
University of Arkansas at Fayetteville
Cancer Genomics and Diagnostics
Genomics and Phylogenetic Studies
Metabolism and Genetic Disorders
Erich A. Peterson
University of Arkansas for Medical Sciences
Cancer Genomics and Diagnostics
Genomics and Phylogenetic Studies
Immune Response and Inflammation